133 related articles for article (PubMed ID: 37594084)
21. [Retracted] Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both
Tang B; Li Y; Yuan S; Tomlinson S; He S
Int J Oncol; 2023 May; 62(5):. PubMed ID: 36928526
[TBL] [Abstract][Full Text] [Related]
22. [Retracted] MicroRNA‑663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF‑β1.
Li Q; Cheng Q; Chen Z; Peng R; Chen R; Ma Z; Wan X; Liu J; Meng M; Peng Z; Jiang B
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35506455
[TBL] [Abstract][Full Text] [Related]
23. [Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR‑181a‑5p/ROCK2 axis.
Chi J; Liu S; Wu Z; Shi Y; Shi C; Zhang T; Xiong B; Zeng Y; Dong X
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38038159
[TBL] [Abstract][Full Text] [Related]
24. [Retracted] Arnebin‑1 promotes angiogenesis by inducing eNOS, VEGF and HIF‑1α expression through the PI3K‑dependent pathway.
Zeng Z; Huang WD; Gao Q; Su ML; Yang YF; Liu ZC; Zhu BH
Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026507
[TBL] [Abstract][Full Text] [Related]
25. [Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799158
[TBL] [Abstract][Full Text] [Related]
26. [Retracted] MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
Zhang C; Hu Y; Wan J; He H
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109991
[TBL] [Abstract][Full Text] [Related]
27. [Retracted] SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling.
Wang H; Liu H; Chen K; Xiao J; He K; Zhang J; Xiang G
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083064
[TBL] [Abstract][Full Text] [Related]
28. [Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642668
[TBL] [Abstract][Full Text] [Related]
29. [Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.
Liu Y; Li Y; Liu J; Wu Y; Zhu Q
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37350407
[TBL] [Abstract][Full Text] [Related]
30. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Qu Y; Xia P; Zhang S; Pan S; Zhao J
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
[TBL] [Abstract][Full Text] [Related]
31. [Retracted] miRNA‑1207‑5p is associated with cancer progression by targeting stomatin‑like protein 2 in esophageal carcinoma.
Yang X; Zang W; Xuan X; Wang Z; Liu Z; Wang J; Cui J; Zhao G
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36562357
[TBL] [Abstract][Full Text] [Related]
32. [Retracted] Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non‑coding RNA MALAT1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606514
[TBL] [Abstract][Full Text] [Related]
33. [Retracted] MicroRNA‑758 inhibits tumorous behavior in tongue squamous cell carcinoma by directly targeting metadherin.
Zhang Y; Zhao F
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37114565
[TBL] [Abstract][Full Text] [Related]
34. [Retracted] Small interfering RNA‑induced silencing of galectin‑3 inhibits the malignant phenotypes of osteosarcoma
Lei P; He H; Hu Y; Liao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296294
[TBL] [Abstract][Full Text] [Related]
35. [Retracted] MicroRNA‑1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
Liu C; Liu Z; Li X; Tang X; He J; Lu S
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37615195
[TBL] [Abstract][Full Text] [Related]
36. [Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R.
Li J; Li D; Zhang W
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36169172
[TBL] [Abstract][Full Text] [Related]
37. [Retracted] CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.
Liu Y; Bian T; Feng J; Qian L; Li X; Zhang Q; Zhang J; Jiang D; Liu J; Shi J
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326128
[TBL] [Abstract][Full Text] [Related]
38. [Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36102301
[TBL] [Abstract][Full Text] [Related]
39. [Retracted] SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539753
[TBL] [Abstract][Full Text] [Related]
40. [Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.
Wang Q; Wang J; Niu S; Wang S; Liu Y; Wang X
Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
